GSK plc (LSE:GSK) Annual Report 2021



The latest annual report of GSK plc (GSK) was published on 31 Dec 2021. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - GSK Annual Results

Amounts in GBP

Total Revenue
34.11B
Gross Profit
22.66B
EBIT
7.97B
Net Tangible Assets
-25.58B
Net Income
4.38B
Capital Expenditures
-1.17B

GSK Income Statement 2021 Annual Report

As per the latest Income Statement of GSK, the Net revenue increased by £15.00M (0%) compared to the previous period. The operating income in 2021 decreased by £-469.00M (-6%). The net income as per the annual report was 4.38B which decreased by £-1.364B (-24%) compared to previous year.

Income Statement Report (2021/2020)

20212020
Total Revenue34.11B34.1B
Gross Profit22.66B23.21B
Operating Income7.97B8.44B
Income Before Tax5.44B6.97B
Net Income4.38B5.75B

Balance Sheet - GSK 2021 Annual Report

Read further: GSK Balance Sheet Detailed Analysis

The latest balance sheet from annual result of GSK plc showed the company reduced the cash on balance sheet by £-2.018B (-32%). The Net tangible assets of GSK on the balance sheet were at -25.58B which is £258.00M (1%) more than previous annual report. The total stockholder equity also increased by £468.00M (3%) compared to previous reporting period.

Balance Sheet Statement Report (2021/2020)

20212020
Cash4.27B6.29B
Total Assets79.1B 80.43B
Long Term Debt19.76B22.54B
Total Liabilities57.76B 59.62B
Total Shareholder Equity15.05B14.59B
Net Tangible Assets-25.58B-25.83B

Cash Flow Statement - GSK 2021 Annual Report

The 2021 annual cash flow statement of GSK plc showed that the net income decreased by £-1.364B (-24%) compared to previous reporting period. Also the capital expenditure of GSK increased by £54.00M (4%).

As of 2021, the total cash from investing activities was -1.78B and total cash from financing activities was -7.59B.

Cash Flow Statement Report (2021/2020)

20212020
Net Income4.38B5.75B
Capital Expenditures-1.17B-1.23B
Dividends Paid-4B-3.98B
Total Cash From From Investing Activities-1.78B2.16B
Total Cash From From Financing Activities-7.59B-10.13B

GSK plc Annual Report History

Income Statement

Income Statement history of GSK plc (LSE:GSK)

31 Dec 202131 Dec 202031 Dec 201931 Dec 2018
Total Revenue34.11B34.1B33.75B30.82B
Cost Of Revenue11.45B10.89B10.79B9.71B
Gross Profit22.66B23.21B22.96B21.11B
Research Development4.88B4.68B4.41B3.8B
Selling General Administrative10.19B10.5B10.96B9.5B
Non Recurring----
Other Operating Expenses-373M-407M-606M313M
Total Operating Expenses26.15B25.66B25.55B23.33B
Operating Income7.97B8.44B8.2B7.5B
Total Other Income Expense Net-2.52B-1.47B-1.98B-2.69B
Ebit7.97B8.44B8.2B7.5B
Interest Expense-775M-860M-877M-756M
Income Before Tax5.44B6.97B6.22B4.8B
Income Tax Expense346M580M953M754M
Minority Interest6.29B6.22B6.95B-109M
Net Income From Continuing Ops5.1B6.39B5.27B4.05B
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income4.38B5.75B4.64B3.62B
Net Income Applicable To Common Shares4.38B5.75B4.64B3.62B

Balance Sheet Statement

Balance Sheet Statement history of GSK plc (LSE:GSK)

31 Dec 202131 Dec 202031 Dec 201931 Dec 2018
Cash4.27B6.29B4.71B3.87B
Short Term Investments614M480M786M419M
Net Receivables7.48B6.86B6.44B5.95B
Inventory5.78B6B5.95B5.48B
Other Current Assets133M195M941M658M
Total Current Assets18.67B20.25B19.49B16.93B
Long Term Investments2.28B3.5B2.28B1.56B
Property Plant Equipment10.67B11.01B11.31B11.06B
Good Will10.55B10.6B10.56B5.79B
Intangible Assets30.08B29.82B30.95B17.2B
Other Assets6.85B5.26B5.09B5.53B
Deferred Long Term Asset Charges5.22B4.29B4.1B3.89B
Total Assets79.1B80.43B79.69B58.07B
Accounts Payable4.54B4.36B4.14B3.65B
Short Long Term Debt2.69B2.45B1.71B1.37B
Other Current Liab5.56B5.4B4.78B5.23B
Long Term Debt19.76B22.54B22.58B20.23B
Other Liab13.52B14.05B13.7B11.63B
Minority Interest6.29B6.22B6.95B-109M
Total Current Liabilities23.67B22.15B24.05B22.49B
Total Liab57.76B59.62B61.34B54.39B
Common Stock1.35B1.35B1.35B1.34B
Retained Earnings8.75B7.29B5.05B-2.7B
Treasury Stock1.66B2.67B1.83B2.05B
Capital Surplus3.3B3.28B3.17B3.09B
Other Stockholder Equity1.66B2.67B1.83B2.05B
Total Stockholder Equity15.05B14.59B11.4B3.78B
Net Tangible Assets-25.58B-25.83B-30.11B-19.21B

Cash Flow Statement

Cash Flow Statement history of GSK plc (LSE:GSK)

31 Dec 202131 Dec 202031 Dec 201931 Dec 2018
Net Income4.38B5.75B4.64B3.62B
Depreciation2.15B2.11B2.33B1.86B
Change To Netincome993M-838M769M3.17B
Change To Account Receivables-782M-224M-32M-429M
Change To Liabilities284M225M263M131M
Change To Inventory25M119M300M51M
Change To Operating Activities670M1.06B-259M18M
Total Cash From Operating Activities7.95B8.44B8.02B8.42B
Capital Expenditures-1.17B-1.23B-1.26B-1.34B
Investments334M2.85B-199M-165M
Other Cashflows From Investing Activities36M70M89M111M
Total Cashflows From Investing Activities-1.78B2.16B-5.35B-1.55B
Dividends Paid-4B-3.98B-3.95B-3.93B
Net Borrowings-2.21B-4.23B3.52B8.12B
Other Cashflows From Financing Activities-1.4B-1.95B-1.45B-10.66B
Total Cash From Financing Activities-7.59B-10.13B-1.84B-6.39B
Effect Of Exchange Rate-29M-39M-82M8M
Change In Cash-1.44B431M744M487M
Issuance Of Stock21M29M51M74M